dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.

Emicizumab: prices and alternatives

Emicizumab is a bispecific antibody indicated for routine prophylaxis to prevent or reduce bleeding episodes in adult and pediatric patients (including newborns) with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors.

4 products with this active ingredient from 2 manufacturers. Official prices from 76539 to 276184 EGP.

Every box with this active ingredient, cheapest first.

Hemlibra 30mg/ml s.c. vialHemlibra 30mg/ml s.c. vialهيمليبرا 30مجم/مل تحت الجلد فيالemicizumab · F.hoffman La RocheOfficial public price76539EGP
Hemlibra 60mg/0.4ml s.c. vialHemlibra 60mg/0.4ml s.c. vialهيمليبرا 60مجم/0.4 مل فيال تحت الجلدemicizumab · Roche / F.hoffman La RocheOfficial public price119014EGP
Hemlibra 105mg/0.7ml s.c. vialHemlibra 105mg/0.7ml s.c. vialهيمليبرا 105مجم/0.7 مل فيال تحت الجلدemicizumab · F.hoffman La RocheOfficial public price263560EGP
Hemlibra 150mg/ml s.c. vialHemlibra 150mg/ml s.c. vialهيمليبرا 150مجم/مل فيال تحت الجلدemicizumab · Roche / F.hoffman La RocheOfficial public price276184EGP

Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.